List of presentations - (1991-2007)                                                      

18. Prof. O. Nativ (Bnai-Zion, IL), Fred Witjes (Nijmegen NL), Renzo Colombo (HSR, IT), Dov Engelstein, Ofer Gofrit (Hadassah, IL) Combined Mitomycin C and Hyperthermia (Synergo) for Patients with Superficial Bladder Cancer (SBC) after Bacillus Calmette-Guerin (BCG) Failure.
AUA, May 2007

17. Prof. F.Witjes, K. Hendricksen (Nijmegen NL), O. Gofrit (Hadassah IL), O. Risi (Triviglio, IT), O.Nativ (BnaiZion, IL)
Intravesical hyperthermia and Mitomycin-C for (BCG refractory) Carcinoma in Situ of the Urinary Bladder.
Presented at the EAU, Berlin 2007

16. Gofrit O.N, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes J.A, Van Der Heijden A.G, Naspro R, Colombo R.
Combined Local Bladder Hyperthermia and Intravesical Chemotherapy for the Treatment of High Grade Superficial Bladder Cancer.
Presented at the A.U.A annual congress, San Francisco, 2004.

15. Sidi A, Nativ O, Witjes J.A, Pavone-Macaluso M, Alken P, Shapiro A, Leib, Z, Serretta V, Siegsmund M, Tarnopolsky A, Gofrit O, Van Der Heijden A.G, Da Pozzo L.F, Salonia A,
Wald M, Florio A, De Carolis D, Colombo R.
Neo Adjuvant Treatment Modality in Intermediate- High Risk Superficial Transitional Cell Carcinoma of the Bladder Facing Cystectomy: A Multicenter Study.
Presented at the A.U.A annual congress, Chicago, 2003.

14. Colombo R, Da Pozzo L.F, Salonia A, Rigatti P, Leib Z, Baniel J, Caldarera E, Pavone-Macaluso M.
Intravesical Chemotherapy alone versus Intravesical Thermo- Chemotherapy for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma: A Multicenter Study.
Presented at the A.U.A annual congress, Chicago, 2003.

13. Tavdy E, Tarnopolsky A, Benjamin S, Mogutin B, Sidi A.
Neoadjuvant Combined Microwave Induced Local Hyperthermia and Topical Chemotherapy in Superficial TCC of Bladder.
Presented at the Israeli Urology Association Conference, Eilat, 2002.

12. Gofrit O, Wald M, Sidi A, Nativ O, Pode D, Shapiro A.
Synergo - chemotherapy treatment in patients with refractory bladder TCC.
Presented at the Israel Urology Association Conference, Eilat, 2001.

11. Salonia A, Colombo R, Lev A, Da Pozzo L.F, Montorsi F, Rigatti L, Bua L, Rigatti P, Paroni R.
Pharmacokinetics of mitomycin C in patients treated with local microwave-induced hyperthermia.
Presented at the XIVth E.A.U Congress, Stockholm, 1999.

10. Colombo R, Da Pozzo L.F, Lev A, Gallus G, Salonia A, Freschi M, Rigatti P, Leib Z,
Baniel J, Caldarera E, Pavone-Macaluso M.
Adjuvant microwave hyperthermia and mitomycin C versus mitomycin C alone for superficial bladder cancer.
Presented at the XIVth E.A.U Congress, Stockholm, 1999. (Eur Urol 35(2):39;1999).

9. Colombo R, Brausi M, Da Pozzo L.F, Salonia A, Montorsi F, Scattoni V, Raber M, Rigatti P.
Thermochemotherapy and electromotive drug administration of mitomycin C in superficial
bladder tumors eradication. A clinical trial on marker lesion.
Presented at the XIVth E.A.U. Congress, Stockholm, 1999. (Eur Urol 35(2):25;1999).

8. Da Pozzo L.F, Colombo R, Lev A, Salonia A, Rigatti P.
Combined thermo-chemotherapy for recurrent superficial bladder tumors:
Results of a preliminary study using epirubicin.
Presented at the XIIIth E.A.U Congress, Barcelona, 1998.

7. Da Pozzo L.F, Colombo R, Salonia A, Lev A, Grasso M, Montorsi F, Rigatti P, Gallus G, Leib Z,
Baniel J, Caldarera E, Biancorosso M, Pavone-Macaluso M.
Studio multicentrico randomizzato mitomicina C vs. mitomicina C + ipertermias endocavitaria nella profilassi delle neoplasie vescicali superficiali.
Presented at the Società Italiana di Urologia (S.I.U) Congress, 1998.

6. Da Pozzo L.F, Colombo R, Lev A, Gallus G, Salonia A, Rigatti P, Leib Z, Baniel J,
Pavone-Macaluso M, Caldarera E.
Microwave hyperthermia + mitomycin C versus mitomycin C alone in the prophylaxis of superficial transitional bladder cancer.
Presented at the A.U.A. Congress, San Diego, CA, 1998.

5. Salonia A, Colombo R, Lev A, Da Pozzo L.F, Rigatti D, Pompa P, Rigatti P, Paroni R,
Arcelloni C, De Vecchi E, Fermo I.
Quantificazione in HPLC della concentrazione plasmatica di mitomicina C in pazienti affetti da neoplasie vescicali superficiali sottoposti a termochemioterapia topica.
Presented at the Società Italiana di Urologia (S.I.U) Congress, 1998.

4. Da Pozzo L.F, Colombo R, Lev A, Salonia A, Rigatti P, Caldarera E,
Pavone-Macaluso M, Leib Z, Servadio C.
Bladder sparing treatment combining local microwave hyperthermia and chemotherapy for multifocal unresectable superficial bladder tumors.
Presented at the A.U.A. Congress, New Orleans, 1997.

3. Da Pozzo L.F, Colombo R, Salonia A, Lev A, Grasso M, Montorsi F, Rigatti P, Leib Z,
Baniel J, Caldarera E, Pavone-Macaluso M.
Studio multicentrico randomizzato mitomicina C vs. mitomicina C + ipertermia endocavitaria nella profilassi delle neoplasie vescicali superficiali.
Presented at the Società Italiana di Urologia (S.I.U) Congress, 1997.

2. Da Pozzo L.F, Colombo R, Lev A, Rigatti P, Leib Z, Servadio C, Caldarera E, Pavone-Macaluso M.
Intravesical microwave-induced hyperthermia and mitomycin C for selected multifocal unresectable superficial bladder tumors.
Presented at the XIIth E.A.U Congress, Paris, 1996.

1. Leib Z, Baniel J, Servadio C, Colombo R, Da Pozzo L.F, Lev A, Rigatti P,
Caldarera E, Pavone-Macaluso M.
mitomycin C (MMC) vs. MMC combined with local microwave hyperthermia (LMWH) as prophylaxis of recurrence of superficial transitional bladder cancer: A preliminary report.
Presented at the XIIth E.A.U Congress, Paris, 1996.

 
 
Medical Enterprises Europe B.V. Assumburg 152B 1081GC, Amsterdam, The Netherlands Tel: +31 (0) 20 6423719 Fax: +31 (0) 20 6421161
R&D Center: MEL Medical Enterprises Ltd. 6 Odem St. P.O.B. 7166 Petah-Tikva, 49170, ISRAEL Tel: 972 3 9244830 Fax: 972 3 9245340
medical-enterprises.com